thumbnail image


  • Home
  • …  
    • Home


  • Home
  • …  
    • Home
  • Home
  • About us
    • Overview
    • Vision, Mission, and Values
    • Company presentation
    • Contact us
  • Patient
    • Overview
    • LVGN6051
    • LVGN7409
    • LVGN1673
    • LVGN3616
    • Resources
  • Science
    • Pipeline
    • xLinkAbTM platform
    • CD137/4-1BB
    • CD40
    • PD-1
    • Publications
  • Media
    • Press release
    • Company presentation
    • Lyvgen Journal
  • Partner
    • Careers
    • Research
    • Business
    • Clinical Trial
    • Contact us
  • Search
    • Company presentation

      Contact us

       沪公网安备 31011502015346号|沪ICP备20018873号-2

      Home
      About us
      xLinkAb
      Pipeline
    礼进生物(Lyvgen)的网站
    Lyvgen is a biopharmaceutical company focused on developing novel therapies for cancer. Lyvgen’s xLinkAb™ functional platform creates agonist antibodies (Abs) with tumor-localized immunostimulatory activities by balancing multiple functions of candidate Abs.
    https://user-assets.sxlcdn.com/images/676507/FiTA8WK-FQRyXrQDyd-HDkY3tpfI.png?imageMogr2/strip/auto-orient/thumbnail/1200x630>/format/png
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More